Babesiosis Treatment Market

Babesiosis treatment sales will strengthen through 2036, anchored by generic drugs at 62.5% of the drug type segment in 2026. Oral administration leads the route of administration segment with a 54.3% share. The market is projected to reach USD 1.4 billion in 2026 and USD 2.33 billion by 2036.